Sangmin Lee MD

Assistant Professor, Medicine, Weill Cornell Medical College

520 E 70th St. Starr 341New York, NY 10021
Phone+1 646-962-2700
Fax+1 646-962-0115

Dr. Lee is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile Already have an account?

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
University of Alabama Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Miami Leonard M. Miller School of MedicineClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2010 - 2028
GA State Medical License 2023 - 2027
AL State Medical License 2009 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017

Clinical Trials

The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery
COMPLETED
NA

Publications & Presentations

PubMed

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov
Blood Advances. 2026-02-24
43 citations
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati
Blood. 2023-02-09
86 citations
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee
The Lancet. Haematology. 2023-01-01

Journal Articles

Somatic Mutations Precede Acute Myeloid Leukemia Years Before Diagnosis
Sangmin Lee, Pinkal Desai, Gail J Roboz, Ellen K Ritchie, Nature

Abstracts/Posters

Olutasidenib (FT-2102) Induces Rapid Remissions in Patients with IDH1-Mutant Myelodysplastic Syndrome: Results of Phase 1/2 Single Agent Treatment and Combination with...
Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms
Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory Myelofibrosis
Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Eltanexor (KPT-8602), a Second-Generation Selective Inhibitor of Nuclear Export (SINE) Compound, in Patients with Higher-Risk Myelodysplastic Syndrome
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Combinations of Modifiable Lifestyle Behaviours in Relation to Colorectal Cancer Risk in Alberta’s Tomorrow ProjectNovember 25th, 2020
Debate: CML Patients with Molecular Response Should Stop Taking TKIsJanuary 1st, 2020
Optimizing Care in Patients with Chronic Myelogenous LeukemiaNovember 20th, 2019